Unique Capabilities of Genome Sequencing for Rare Disease Diagnosis
Wojcik, M. H.; Lemire, G.; Zaki, M. S.; Wissmann, M.; Win, W.; White, S.; Weisburd, B.; Waddell, L. B.; Verboon, J. M.; VanNoy, G. E.; Topf, A.; Tan, T. Y.; Straub, V.; Stenton, S. L.; Snow, H.; Singer-Berk, M.; Silver, J.; Shril, S.; Seaby, E. G.; Schneider, R.; Sankaran, V. G.; Sanchis-Juan, A.; Russell, K. A.; Reinson, K.; Ravenscroft, G.; Pierce, E. A.; Place, E. M.; Pajusalu, S.; Pais, L.; Ounap, K.; Osei-Owusu, I.; Okur, V.; Oja, K. T.; OLeary, M.; OHeir, E.; Morel, C.; Marchant, R. G.; Mangilog, B. E.; Madden, J. A.; MacArthur, D.; Lovgren, A.; Lerner-Ellis, J. P.; Lin, J.; Laing, N.; H
Show abstract
BackgroundCausal variants underlying rare disorders may remain elusive even after expansive gene panels or exome sequencing (ES). Clinicians and researchers may then turn to genome sequencing (GS), though the added value of this technique and its optimal use remain poorly defined. We therefore investigated the advantages of GS within a phenotypically diverse cohort. MethodsGS was performed for 744 individuals with rare disease who were genetically undiagnosed. Analysis included review of single nucleotide, indel, structural, and mitochondrial variants. ResultsWe successfully solved 218/744 (29.3%) cases using GS, with most solves involving established disease genes (157/218, 72.0%). Of all solved cases, 148 (67.9%) had previously had non-diagnostic ES. We systematically evaluated the 218 causal variants for features requiring GS to identify and 61/218 (28.0%) met these criteria, representing 8.2% of the entire cohort. These included small structural variants (13), copy neutral inversions and complex rearrangements (8), tandem repeat expansions (6), deep intronic variants (15), and coding variants that may be more easily found using GS related to uniformity of coverage (19). ConclusionWe describe the diagnostic yield of GS in a large and diverse cohort, illustrating several types of pathogenic variation eluding ES or other techniques. Our results reveal a higher diagnostic yield of GS, supporting the utility of a genome-first approach, with consideration of GS as a secondary or tertiary test when higher-resolution structural variant analysis is needed or there is a strong clinical suspicion for a condition and prior targeted genetic testing has been negative.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- IGenomic answers for children: Dynamic analyses of >1000 pediatric rare disease genomes 97%
- Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing datasets 96%
- The Australian Genomics Mitochondrial Flagship: A National Program Delivering Mitochondrial Diagnoses 96%
Similar papers in this journal
- Genome Sequencing and Comprehensive Rare Variant Analysis of 465 Families with Neurodevelopmental Disorders 97%
- Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease 97%
- Extracting and calibrating evidence of variant pathogenicity from population biobank data 94%
Similar papers in this journal
- Genetic Diagnosis of Facioscapulohumeral Muscular Dystrophy Type 1 Using Rare Variant Linkage Analysis and Long Read Genome Sequencing 94%
- Detection and characterisation of copy number variants from exome sequencing in the DDD study 92%
- Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity 92%
Similar papers in this journal
- Long-read genome sequencing for the diagnosis of neurodevelopmental disorders 95%
- Identification and validation of novel candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas 93%
- Whole Genome Sequencing for the Diagnosis of Rare Disorders 92%
Similar papers in this journal
- Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses 95%
- Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort 93%
- Diagnostic Yield of Exome Sequencing in a Diverse Pediatric and Prenatal Population is not Associated with Genetic Ancestry 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.